Compare Quest Diagnostics Inc (DGX) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Vanguard High Dividend Yield ETF — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 4× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| DGX | VYM | |
|---|---|---|
Market Cap | $25.48B | $100.80B |
Volume | 941,866 | 908,176 |
Sector | Health | — |
52-Week High | $247.45 | $167.03 |
52-Week Low | $173.49 | $137.47 |
Typical Hold Time | 56 Days | 139 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.
DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.
VYM trades at $158.25, up 0.51% with a bearish technical signal. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $156 and resistance at $159. Recent news highlights VYM's consistent dividend yield of 2.42% but notes competitive pressure from alternatives like SCHD and IDV, which have outperformed recently. The fund's index methodology has faced criticism for holding stocks like Intel and Walgreens through dividend cuts.
Outlook remains cautious due to technical bearishness and competitive headwinds. While VYM offers broad diversification and low costs, investors face risks from its yield-focused strategy potentially including dividend-cut vulnerable stocks. The fund serves income investors but may underperform more dynamic dividend strategies in current market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
